Literature DB >> 10631982

Structure of the fibrinogen gamma-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization.

S Ware1, J P Donahue, J Hawiger, W F Anderson.   

Abstract

The human fibrinogen gamma-chain C-terminal segment functions as the platelet integrin binding site as well as the Factor XIIIa cross-linking substrate and thus plays an important role in blood clot formation and stabilization. The three-dimensional structure of this segment has been determined using carrier protein driven crystallization. The C-terminal segment, gamma-(398-411), was attached to a linker sequence at the C-terminus of glutathione S-transferase and the structure of this fusion protein determined at 1.8 A resolution. Functional studies of the chimeric protein demonstrate that the fibrinogen sequence in the presence of the carrier protein retains its specific functions as ligand for platelet integrin alpha(IIb)beta3 (gpIIb/IIIa) and as a cross-linking substrate for Factor XIIIa. The structure obtained for the fibrinogen gamma-chain segment is not affected by crystal packing and can provide the missing links to the recently reported model of cross-linked fibrin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631982      PMCID: PMC2144222          DOI: 10.1110/ps.8.12.2663

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

1.  Platelet membrane glycoprotein IIb-IIIa complex: purification, characterization, and reconstitution into phospholipid vesicles.

Authors:  D R Phillips; L Fitzgerald; L Parise; B Steiner
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

Review 2.  The molecular replacement method.

Authors:  M G Rossmann
Journal:  Acta Crystallogr A       Date:  1990-02-01       Impact factor: 2.290

3.  Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen.

Authors:  V C Yee; K P Pratt; H C Côté; I L Trong; D W Chung; E W Davie; R E Stenkamp; D C Teller
Journal:  Structure       Date:  1997-01-15       Impact factor: 5.006

Review 4.  Structural aspects of the fibrinogen to fibrin conversion.

Authors:  R F Doolittle
Journal:  Adv Protein Chem       Date:  1973

5.  - cross-linking sites in human and bovine fibrin.

Authors:  R Chen; R F Doolittle
Journal:  Biochemistry       Date:  1971-11-23       Impact factor: 3.162

Review 6.  Adhesive ends of fibrinogen and its antiadhesive peptides: the end of a saga?

Authors:  J Hawiger
Journal:  Semin Hematol       Date:  1995-04       Impact factor: 3.851

7.  Characterization of a complementary deoxyribonucleic acid coding for the gamma chain of human fibrinogen.

Authors:  D W Chung; W Y Chan; E W Davie
Journal:  Biochemistry       Date:  1983-06-21       Impact factor: 3.162

8.  Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxy-terminal cyanogen bromide gamma-chain fragments.

Authors:  L Purves; M Purves; W Brandt
Journal:  Biochemistry       Date:  1987-07-28       Impact factor: 3.162

9.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

10.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.

Authors:  G Spraggon; S J Everse; R F Doolittle
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

View more
  22 in total

1.  Addition of missing loops and domains to protein models by x-ray solution scattering.

Authors:  Maxim V Petoukhov; Nigel A J Eady; Katherine A Brown; Dmitri I Svergun
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

Review 2.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

Review 3.  To fuse or not to fuse: what is your purpose?

Authors:  Mark R Bell; Mark J Engleka; Asim Malik; James E Strickler
Journal:  Protein Sci       Date:  2013-09-17       Impact factor: 6.725

4.  Thioredoxin as a fusion tag for carrier-driven crystallization.

Authors:  Lorenzo Corsini; Michael Hothorn; Klaus Scheffzek; Michael Sattler; Gunter Stier
Journal:  Protein Sci       Date:  2008-09-09       Impact factor: 6.725

5.  A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A.

Authors:  Champion C S Deivanayagam; Elisabeth R Wann; Wei Chen; Mike Carson; Kanagalaghatta R Rajashankar; Magnus Höök; Sthanam V L Narayana
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

Review 6.  Pathogenesis of Staphylococcus aureus Bloodstream Infections.

Authors:  Lena Thomer; Olaf Schneewind; Dominique Missiakas
Journal:  Annu Rev Pathol       Date:  2016-02-25       Impact factor: 23.472

7.  Mechanistic Basis for the Binding of RGD- and AGDV-Peptides to the Platelet Integrin αIIbβ3.

Authors:  Olga Kononova; Rustem I Litvinov; Dmitry S Blokhin; Vladimir V Klochkov; John W Weisel; Joel S Bennett; Valeri Barsegov
Journal:  Biochemistry       Date:  2017-03-22       Impact factor: 3.162

8.  Sortases, Surface Proteins, and Their Roles in Staphylococcus aureus Disease and Vaccine Development.

Authors:  Olaf Schneewind; Dominique Missiakas
Journal:  Microbiol Spectr       Date:  2019-01

9.  Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.

Authors:  Shan Liu; Xiaozhou Feng; Rong Jin; Guohong Li
Journal:  Expert Opin Drug Deliv       Date:  2017-09-28       Impact factor: 6.648

10.  Mechanistic strategies for catalysis adopted by evolutionary distinct family 43 arabinanases.

Authors:  Camila R Santos; Carla C Polo; Maria C M F Costa; Andrey F Z Nascimento; Andreia N Meza; Junio Cota; Zaira B Hoffmam; Rodrigo V Honorato; Paulo S L Oliveira; Gustavo H Goldman; Harry J Gilbert; Rolf A Prade; Roberto Ruller; Fabio M Squina; Dominic W S Wong; Mário T Murakami
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.